Clorazepate Dipotassium
NADAC/unit
$0.6138
No Shortage
Tier 1: 62.0%
PA Req: 131.3%
4 Manufacturers
12 ANDAs
Market Intelligence
2024-05-15 Class II Recall: Aurobindo Pharma USA Inc.
2024-05-15 Class II Recall: Aurobindo Pharma USA Inc.
Generic Manufacturers
AJENAT PHARMACEUTICALS LLCAUROBINDO PHARMA LTDCOREPHARMA LLCNOVITIUM PHARMA LLCTARO PHARMACEUTICAL INDUSTRIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
